"At The AIS Cancer Center, our team of board-certified oncologists are renowned, highly respected and offer the very latest advances in treatment for all types and stages of cancer. From accurate diagnosis, to advanced treatment and ongoing follow-up care and survivorship, they work together to assess your needs and coordinate your care. Our oncology team works together with experts at UC Davis to help patients access clinical trials, and they discuss patient cases at multidisciplinary tumor boards. Patients can also benefit from access to clinical trials with UCLA for radiation oncology as well."

During the past decade, AIS Cancer Center at San Joaquin Community Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 17 clinical trials were completed, i.e. on average, 77.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 14 clinical trials were completed. i.e. 1400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AIS Cancer Center at San Joaquin Community Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "SWOG Cancer Research Network" with 10 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "NRG Oncology" with 3 trials sponsored and "Radiation Therapy Oncology Group" with 3 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AIS Cancer Center at San Joaquin Community Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "AIS Cancer Center at San Joaquin Community Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (5 trials), "Breast Carcinoma" (3 trials), "Recurrent Breast Carcinoma" (3 trials) and "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials). Many other conditions were trialed in "AIS Cancer Center at San Joaquin Community Hospital" in a lesser frequency.

Most popular intervention types in "AIS Cancer Center at San Joaquin Community Hospital" are "Drug" (26 trials), "Other" (25 trials), "Biological" (12 trials), "Procedure" (11 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (16 trials), "Biospecimen Collection" (7 trials), "Nivolumab" (7 trials), "Crizotinib" (5 trials) and "Quality-of-Life Assessment" (5 trials). Other intervention names were less common.

The vast majority of trials in "AIS Cancer Center at San Joaquin Community Hospital" are 33 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "AIS Cancer Center at San Joaquin Community Hospital". undefined are not yet recruiting, 4 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in AIS Cancer Center at San Joaquin Community Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in AIS Cancer Center at San Joaquin Community Hospital, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".